Delivery Order SPE2DB20D2014-SPE2DB24FD06J

Award Date 9/18/24
Potential Completion Date 9/19/24
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $10,466.46 firm fixed price contract is for the supply of CellCept 500 mg tablets, with an ultimate completion date of September 30, 2024. The contract is not set aside for any special category of vendor. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4565134752 units of CellCept 500 mg tablets. The $7,967.40 firm fixed price contract has a ceiling value and an ultimate completion date of July 15, 2024. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CELLCEPT 500 MG TABLET 500S. The $16,382.12 firm fixed price contract has a period of performance through June 13, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CELLCEPT 500 MG TABLET 500S. The firm-fixed-price contract has a ceiling value of $18,616.73 and a completion date of August 6, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,835.41 firm fixed-price contract is for the delivery of CELLCEPT 500 MG TABLET 500S, a prescription medication. The contract is not set aside and has an ultimate completion date of June 17, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a $3,404.38 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of 100 units of the prescription medication CellCept 250 mg capsules. The delivery order has a completion date of May 13, 2025. AmerisourceBergen Drug Corp holds a large $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of CELLCEPT 500 MG TABLET 100S. The contract has a firm fixed price of $34,204.00 and an ultimate completion date of August 13, 2024. AmerisourceBergen is the prime contractor, and there is no set-aside designation mentioned. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,036.59, is for the delivery of CELLCEPT 500 MG TABLET 500S, a pharmaceutical product, with a completion date of May 20, 2025. The award is not set aside and involves open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,799.28 firm fixed price contract is for the delivery of CELLCEPT 500 MG TABLET 100S, a prescription medication. The award has a completion date of May 19, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CellCept 500 mg tablets, a medication used for organ transplant patients. The contract has a firm fixed price of $8,292.86 and a period of performance through February 14, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FD06J
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of CellCept 500 mg tablets. The $8,140.58 firm-fixed-price contract has an ultimate completion date of September 19, 2024. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to provide a wide range of pharmaceutical and medical supplies to support military treatment programs, veterans' healthcare, and other federal beneficiaries. This contract award does not have a set-aside designation.

Generated 12/18/24, 9:02 AM